Apixaban Alternatives in Indiana
Compare generic and therapeutic alternatives to Apixaban (apixaban) available at Indiana pharmacies. Save up to 78% on your prescription — no insurance required.
Top Alternatives in Indiana
Rivaroxaban (generic Xarelto)
therapeutic
Once-daily DOAC — similar efficacy, slightly different dosing
Avg cash price: $140/mo
Warfarin (generic Coumadin)
therapeutic
Older anticoagulant requiring INR monitoring — far cheaper
Avg cash price: $10/mo
Eliquis (brand apixaban)
brand
Brand name — equivalent drug but 4× more expensive
Avg cash price: $590/mo
Indiana Prescription Assistance Programs
HIP (Healthy Indiana Plan)
Prescription drug coverage through Indiana's Medicaid alternative for low-income adults, including a POWER Account model for cost-sharing.
Eligibility: Indiana adults aged 19–64 with income up to 138% FPL who are not Medicare-eligible or pregnant.
Frequently Asked Questions
Is generic apixaban the same as Eliquis?
Yes — generic apixaban is FDA-approved as bioequivalent to brand Eliquis. It became available in the US in 2023 and typically costs $100–$150/month versus $500+ for brand.
How does apixaban compare to rivaroxaban?
Both are DOACs that require no routine blood monitoring. Apixaban is twice-daily; rivaroxaban is once-daily. Studies suggest apixaban may have a slightly lower bleeding risk, but your cardiologist decides.
Is warfarin a reasonable alternative to apixaban?
Warfarin costs under $15/month but requires regular INR blood tests and dietary restrictions. DOACs like apixaban are preferred for most patients who can afford them.
Can Script Unlock help lower my apixaban cost?
Yes. Script Unlock pharmacies compete on generic apixaban pricing. Many offer cash prices below standard GoodRx rates — worth posting your script to compare.
Can I stop taking apixaban on my own to save money?
Never stop anticoagulation therapy without your doctor's approval — stopping abruptly can cause stroke or blood clots. If cost is a barrier, Script Unlock can help find more affordable options.